2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Trypanosoma Cruzi Infection: new trials by email Literature Review of Trypanosoma Cruzi Infection trials Research Report on Trypanosoma Cruzi Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| New Therapies and Biomarkers for Chagas Infection Benznidazole, Nifurtimox - Trypanosoma Cruzi Infection, Chagas Disease | Phase 2 | Completed | University of Texas, El Paso | 450 | 2019-12-18 | 2024-07-17 |
| Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease. Benznidazole - Chagas Disease, Trypanosoma Cruzi Infection | Phase 2 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 238 | 2017-04-21 | 2023-12-19 |
Chagas Disease (2) · Parasitic Diseases (1)
Euglenozoa Infections (2) · Infections (2) · Protozoan Infections (2) · Trypanosomiasis (2) · Vector Borne Diseases (2) · Parasitic Diseases (1)
benzonidazole (2) · Nifurtimox (1)
Hospital Universitari Vall d'Hebron Research Institute (1) · University of Texas, El Paso (1)
Argentina (1) · Bolivia (1) · Brazil (1) · Colombia (1) · Spain (1)
Faustino Torrico, M.D., Ph.D (1) · Igor C Almeida, D.Sc. (1) · Israel Molina, PhD (1) · Joaquim Gascon, M.D., Ph.D (1)
PMID 32293523, PMID 34972765, PMID 38218195, PMID 42772313
2016 (1), U01AI129783 (1)